Results 81 to 90 of about 6,826 (232)
Molecular Oncology, EarlyView.Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker +14 more
wiley +1 more source
Onderstepoort Journal of Veterinary Research, 2012 Newcastle disease (ND) is regarded as a highly contagious and economically important disease in poultry and has a worldwide distribution. Viral determinants for Newcastle disease virus (NDV) virulence are not completely understood and viruses of ...
Raul Fringe +5 more
doaj
Journal of CheminformaticsAmong the various molecular properties and their combinations, it is a costly process to obtain the desired molecular properties through theory or experiment.
Xiaofan Zheng, Yoichi Tomiura
doaj +1 more source
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Molecular Oncology, EarlyView.Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha +6 more
wiley +1 more source
Research-tool patents: issues for health in the developing world
Bulletin of the World Health Organization, 2002 The patent system is now reaching into the tools of medical research, including gene sequences themselves. Many of the new patents can potentially preempt large areas of medical research and lay down legal barriers to the development of a broad category ...
Barton John H.
doaj
A Molecular Phylogeny of the Blackbirds (Icteridae): Five Lineages Revealed by Cytochrome-B Sequence Data [PDF]
, 1999 Scott M. Lanyon, Kevin E. Omland
openalex +1 more source
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Molecular Oncology, EarlyView.Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini +11 more
wiley +1 more source
MHC Class II Deficiency with Normal CD4+ T Cell Counts: A Case Report
Iranian Journal of Allergy, Asthma and Immunology, 2018 Major histocompatibility complex (MHC) class II deficiency is a rare primary immunodeficiency disorder (PID) with less than 200 cases worldwide. Here, we report an 8 month–old girl with MHC class II deficiency with a novel homozygous mutation in RFXANK ...
Farhad Abolnezhadian +2 more
doaj +1 more source
A molecular systematic investigation of the Acrochaetiales (Florideophycidae, Rhodophyta) and related taxa based on nuclear small-subunit ribosomal DNA sequence data [PDF]
, 1998 JAMES T. HARPER, Gary W. Saunders
openalex +1 more source
Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
Molecular Oncology, EarlyView.Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi +6 more
wiley +1 more source